Cargando…
Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life
Hemophilia A is a rare inherited bleeding disorder characterized by a deficiency in factor VIII. The evolution of currently approved prophylaxis therapy in hemophilia A will be reviewed, including the clinical value of prophylaxis, real-world experience with prophylaxis, and patient quality-of-life...
Autores principales: | Escobar, Miguel A., Leissinger, Cindy, Young, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236157/ https://www.ncbi.nlm.nih.gov/pubmed/35769336 http://dx.doi.org/10.6004/jadpro.2022.13.4.8 |
Ejemplares similares
-
Acquired hemophilia A: emerging treatment options
por: Janbain, Maissaa, et al.
Publicado: (2015) -
Strategies to encourage physical activity in patients with hemophilia to improve quality of life
por: Goto, Miwa, et al.
Publicado: (2016) -
Treatment Adherence and Health-Related Quality of Life in Patients with Hemophilia in Hong Kong
por: Cheung, Yin Ting, et al.
Publicado: (2022) -
Treatment adherence in hemophilia
por: Thornburg, Courtney D, et al.
Publicado: (2017) -
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
por: Shapiro, Amy D., et al.
Publicado: (2022)